FNY Investment Advisers’s SpringWorks Therapeutics SWTX Stock Holding History

FNY Investment Advisers’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,575	Closed	-$470K	–	1182
2025 Q1	$466K	Buy	+10,575	New	+$487K	0.28%	77

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FNY Investment Advisers's SWTX Position: Q2 2025 in Review

FNY Investment Advisers sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 10,575 shares — an estimated $470K sold.

FNY Investment Advisers first reported a position in SWTX in Q1 2025 and held it in 1 quarter. The position peaked at $466K in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

FNY Investment Advisers reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
FNY Investment Advisers sold 10,575 SpringWorks Therapeutics shares in Q2 2025, an estimated $470K.
FNY Investment Advisers first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 1 quarter.
FNY Investment Advisers's SpringWorks Therapeutics position peaked at $466K in Q1 2025.
222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on FNY Investment Advisers's 13F filing for Q2 2025, filed 30 Jul 2025.